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AbsTrACT
Objective Human intestinal epithelial organoids (ieOs) 
are increasingly being recognised as a highly promising 
translational research tool. However, our understanding 
of their epigenetic molecular characteristics and 
behaviour in culture remains limited.
Design We performed genome-wide Dna methylation 
and transcriptomic profiling of human ieOs derived from 
paediatric/adult and fetal small and large bowel as well 
as matching purified human gut epithelium. Furthermore, 
organoids were subjected to in vitro differentiation and 
genome editing using criSPr/cas9 technology.
results We discovered stable epigenetic signatures 
which define regional differences in gut epithelial 
function, including induction of segment-specific 
genes during cellular differentiation. established Dna 
methylation profiles were independent of cellular 
environment since organoids retained their regional Dna 
methylation over prolonged culture periods. in contrast 
to paediatric and adult organoids, fetal gut-derived 
organoids showed distinct dynamic changes of Dna 
methylation and gene expression in culture, indicative of 
an in vitro maturation. By applying criSPr/cas9 genome 
editing to fetal organoids, we demonstrate that this 
process is partly regulated by tet1, an enzyme involved 
in the Dna demethylation process. lastly, generating 
ieOs from a child diagnosed with gastric heterotopia 
revealed persistent and distinct disease-associated 
Dna methylation differences, highlighting the use of 
organoids as disease-specific research models.
Conclusions Our study demonstrates striking 
similarities of epigenetic signatures in mucosa-derived 
ieOs with matching primary epithelium. Moreover, these 
results suggest that intestinal stem cell-intrinsic Dna 
methylation patterns establish and maintain regional 
gut specification and are involved in early epithelial 
development and disease.
InTrODuCTIOn
The intestinal epithelium is a complex and highly 
dynamic tissue which performs a variety of functions 
including digestion and absorption of nutrients, barrier 
formation and maintenance of intestinal homeostasis. 
Dividing adult stem cells located at the crypt base give 
rise to all major epithelial cell lineages and enable 
complete renewal of the epithelial layer over 3–5 
days. The identification of reliable markers and key 
signalling pathways in adult intestinal stem cells has 
enabled long-term in vitro propagation of intestinal 
stem cells within self-organising three-dimensional 
intestinal epithelial organoids (IEOs).1 2 The ability to 
generate organoids from individual patients provides 
an unprecedented opportunity to investigate human 
epithelial cell biology in health and disease. Moreover, 
significance of this study
What is already known on this subject?
 ► Human intestinal epithelial organoids (IEOs) are 
emerging as translational research tool to study 
epithelial biology  in health and disease.
 ► Early studies described that regional differences 
in intestinal or colonic IEOs are preserved in 
culture.
What are the new findings?
 ► Human IEOs from ileum and colon show a 
stable highly gut segment-specific epigenetic 
DNA methylation profile that closely reflects 
their tissue of origin.
 ► Intrinsically programmed DNA methylation 
signatures define regional identity of the 
human intestinal epithelium.
 ► Human fetal epithelium shows in vitro 
maturation, indicated by greater epigenetic 
plasticity and transcriptional changes in culture.
 ► Human mucosa-derived IEOs are excellent 
models to investigate DNA methylation 
dynamics in GI health, development and 
disease.
How might it impact on clinical practice in the 
foreseeable future?
 ► Demonstrating stable epigenetic signatures in 
IEOs that closely match those of primary cells 
further extends the use of these promising 
culture models as future translational research 
tool in disease modelling, drug discovery and 
regenerative medicine.
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organoids from human fetal gut samples can be used to evaluate 
developmental changes in epithelial cells.3 
Epigenetic mechanisms are critical regulators of mammalian 
development, cellular differentiation and tissue-specific func-
tions. One of the main epigenetic mechanisms is DNA meth-
ylation of cytosine in the context of CpG dinucleotides. The 
role of DNA methylation during intestinal development and 
homeostasis has been studied in freshly isolated human epithe-
lial cells, biopsies and mouse tissues.4–7 However, it remains 
unclear whether DNA methylation signatures in the epithelium 
are a stable cell-intrinsic property or a process dependent on 
external cues. Despite the recognised importance of DNA meth-
ylation in regulating gene expression and the maintenance of 
cellular identity, investigations of IEO culture systems have so 
far mainly relied on gene expression analysis.1 2 8 Indeed, some 
of these studies have demonstrated differences in gene expres-
sion in IEOs derived from distinct regions of the gut.9 Yet, an 
underlying functional mechanism explaining how mucosal IEOs 
retain regional phenotypic differences has not been identified.
Here, we demonstrate the presence of stable, gut segment-spe-
cific DNA methylation signatures in human IEOs, which closely 
reflect those of matching primary purified epithelium and deter-
mine regional transcription and cellular function. In contrast, 
fetal IEOs showed distinct changes in their DNA methylation 
profile over time towards the paediatric pattern, suggesting the 
existence of a cell-intrinsic maturation programme that allows 
development in vitro without the requirement for other cellular 
components. Lastly, we demonstrate that IEOs from diseased 
tissue retains altered DNA methylation signatures, highlighting 
the potential of organoids to model pathophysiology.
MeTHODs
Human intestinal samples
Intestinal biopsies were collected from the terminal ileum (TI) 
and sigmoid colon (SC) from children under 16 years of age 
as well as adults undergoing diagnostic endoscopy. All patients 
included had macroscopically and histologically normal mucosa. 
Fetal intestine was obtained with ethical approval (REC-96/085) 
and informed consent from elective terminations at 8–12-week 
gestational age. Fetal gut was dissected and divided into the 
proximal (small intestine) and distal (large intestine) sections at 
the ileocaecal junction. Sample details are listed in online supple-
mentary tables S1 and S2.
Purification of intestinal epithelial cells
Intestinal epithelial cells (IECs) were purified by enzyme diges-
tion and magnetic bead sorting for the epithelial cell adhesion 
molecule (EpCAM) and purity was assessed as described previ-
ously.7 10
Human intestinal epithelial organoid culture
IEOs were cultured according to protocols by Sato et al and 
Fordham et al2 3 (see online supplementary table S3). Culture 
of gastric organoids followed a protocol adjusted from Schlaer-
mann et al11 (see online supplementary table S4).
rnA and DnA extraction
DNA and RNA were extracted simultaneously from the same 
sample as described previously.7
Genome-wide DnA methylation arrays
Bisulfite-converted DNA was measured using the Infinium 
HumanMethylation450 BeadChip (Illumina, Cambridge, UK). 
The readout for each CpG is expressed as beta value (from 
0=unmethylated to 1=fully methylated) or the log2-beta value 
(M-value). A subset of IEC samples formed part of previous 
publications.7 12
rnA sequencing
RNA sequencing was performed on the Illumina HiSeq 2500 
platform. Further information is provided in the supplement.
In vitro experiments
IEOs were in vitro differentiated by culturing in differentiation 
medium (see online supplementary table S5) for 4 days. For 
Aza-deoxycytidine (AdC) treatment, 1 µM AdC was added for 
48 hours followed by a 4-day AdC-free recovery. For long-term 
AdC treatment, fetal proximal gut -derived IEOs were treated 
once with 1 µM AdC for 48 hours at passage 1 and then main-
tained in regular medium for one or five additional passages.
bisulfite conversion and pyrosequencing
DNA was bisulfite-converted and locus-specific DNA methyl-
ation analysis was performed by pyrosequencing as described 
previously.7 Primer sequences are provided in online supplemen-
tary table S6.
reverse transcription and quantitative PCr
RNA was reverse-transcribed and used in quantitative PCR 
(qPCR) as described previously.7 Relative expression was calcu-
lated using the ΔΔCt method.13 Primer sequences are provided 
in online supplementary table S7.
Immunofluorescence and imaging
Fluorescent and brightfield images were obtained using an EVOS 
FL system (Life Technologies). Organoids were stained using anti-
FABP6, anti-MUC5B (Atlas Antibodies) or anti-EpCAM (abcam) 
antibodies. Further details are provided in the supplement.
Vector construction and genome editing
Plasmid vectors for hCas9 (#41815) and gRNA (#41824) were 
obtained via Addgene. The targeting vector was generated from 
human genomic DNA and assembly into pUC118-FLIP-Puro 
backbone (Addgene #84538).14 Further details are provided in 
the supplement. Human IEOs were electroporated following the 
protocol from Fujii et al.15
statistical analysis
Statistical analysis for qPCR and pyrosequencing data was 
performed using GraphPad Prism V.7.00 (GraphPad). Signifi-
cance levels were determined using multiple t-test with Holm-
Sidak correction.
bioinformatic analysis
Bioinformatic analysis was performed in R software for statis-
tical analysis V.3.2.3 using Bioconductor V.3.2 packages.
DNA methylation data were analysed using minfi16, sva,17 
limma18 and DMRcate19. Minfi was used to generate multidi-
mensional scaling (MDS) plots, which allow visualising similarity 
between large datasets by reducing complexity to a two-dimen-
sional scale. RNA sequencing data were processed using fastq_
illumina_filter, cutadapt20, tophat2,21 bowtie22, samtools23, 
htseq-count,24 RUVseq.25, DESeq226 and GOseq.27 Further details 
are provided in the supplement.
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DATA AVAIlAbIlITy
Genome-wide data have been deposited in ArrayExpress, acces-
sions E-MTAB-4957 (DNA methylation) and E-MTAB-5015 
(RNA sequencing).
resulTs
Paediatric and adult mucosa-derived intestinal organoids 
retain gut segment-specific DnA methylation profiles
To investigate DNA methylation and its role in regulating 
cellular function in human IEOs, we generated organoids from 
mucosal biopsies from healthy children and adolescents from 
the distal small bowel (terminal ileum=TI) and distal large 
bowel (ie, sigmoid colon=SC, figure 1A and online supple-
mentary figure S1A). Additionally, we generated a matching 
reference sample set of primary, highly purified intestinal 
epithelium (sorted for the epithelial cell adhesion molecule 
EpCAM)(figure 1A and refs 7 12). Genome-wide DNA methyla-
tion analysis on these samples demonstrated distinct separation 
of primary epithelium, whole biopsy tissue and non-epithe-
lial, mucosal tissue fraction (figure 1B). Moreover, purified 
primary IEC displayed highly gut segment-specific DNA meth-
ylation profiles as reported previously (figure 1B and refs 7 12). 
Importantly, IEO cultures clustered closely with primary IEC 
samples from the same gut segment, indicating that epithelial 
cells retain a highly gut segment-specific epigenetic profile in 
culture (figure 1B and online supplementary figure S1B). This 
was also the case for organoids generated from adult individ-
uals (age 24–60 years, see online supplementary figure S1C 
and D).
To assess to what extent the DNA methylation profiles of 
organoids reflect gut segment-specific epigenetic signatures 
of primary epithelium, we performed differential methylation 
analysis comparing TI and SC for both organoids and primary 
epithelial samples (supplementary tables S13 and S14) 
(supplementary files 3 and 4). The majority (87%) of signifi-
cantly differentially methylated positions (DMPs) between TI 
and SC organoids were also differentially methylated in the 
respective primary purified TI and SC IEC (figure 1C). Strik-
ingly, DNA methylation levels of these gut segment-specific 
DMPs correlated strongly between IEC and organoids in each 
segment (figure 1D) and the differences (ie, hypo-methyla-
tion/hyper-methylation) occurred in the same direction for 
almost all (99.8%) overlapping DMPs (see online supple-
mentary figure S2A). Combining adjacent DMPs, we iden-
tified several thousand gut segment-specific differentially 
methylated regions (DMRs) between TI and SC with differ-
ences highly preserved in the respective organoids, including 
interleukin-6 receptor (IL6R), special AT-rich sequence-
binding protein 2 antisense 1 (SATB2-AS1) and claudin 15 
(CLDN15) (figure 1E, see online supplementary figure S2B). 
We validated the methylation profiles of selected DMRs with 
pyrosequencing (figure 1F).
Gut segment-specific DnA methylation signatures are stable
Organoids derived from the same gut segment and profiled 
after a range of culture periods (ie, from 1 to 11 passages) 
displayed close clustering in the MDS plot (figure 1B), indi-
cating that gut segment-specific DNA methylation profiles 
are highly stable over prolonged culture periods (up to 3 
months). Furthermore, no statistically significant DMPs 
between low and high passage IEOs were identified in any of 
the gut segments. Additionally, displaying DNA methylation 
of the top 1000 gut segment-specific CpGs highlighted the 
clear clustering of samples according to gut segment with no 
major differences between higher and lower passage organoids 
(Figure 1G). These findings were confirmed by locus-specific 
pyrosequencing of early (passage ≤5) and late (passage ≥10) 
organoids (see online supplementary figure S2C).
Transcriptional profiles of human IeOs display gut segment-
specific signatures of gene expression
In parallel to DNA methylation, we performed transcriptome 
analysis on organoids and primary IEC by RNA-sequencing 
(RNA-seq). Unsupervised hierarchical clustering and sample 
relation analysis of transcriptomes revealed a clear, primary 
separation of samples according to gut segment (figure 2A). 
However, within each gut segment organoids were found 
to separate from primary IEC (figure 2A). The expression 
levels of several key genes involved in intestinal epithelial 
cellular function and/or epigenetic regulation are displayed in 
figure 2B, highlighting both the similarities of samples from 
the same gut segment and the differences between organoids 
and primary IEC. Moreover, in contrast to DMPs, only 56% 
of significantly differentially expressed genes (DEGs) between 
SC-derived and TI-derived organoids overlapped with DEGs 
in the respective IEC (figure 2C). However, the majority of 
overlapping DEGs (98%) showed the same direction when 
comparing TI and SC. Genes that retain gut segment-spe-
cific expression levels in organoid cultures include lysozyme 
(LYZ), the main glucose transporter solute carrier family 5 
member 1 (SLC5A1), CLDN15, cystic fibrosis transmembrane 
conductance regulator (CFTR) as well as SATB2 (figure 2D). 
We confirmed expression patterns of some of these key genes 
identified above by quantitative real-time PCR in an additional 
sample set (figure 2E; DNA methylation levels are provided 
in online supplementary figure S3).
DnA methylation is stable during in vitro differentiation of 
IeOs and regulates induction of gut segment-specific gene 
expression
We hypothesised that the transcriptional differences between 
organoids and IEC might arise in part from the enrichment for 
the stem cell niche in maintenance organoid culture. We there-
fore subjected organoids to in vitro differentiation that mimics 
migration upwards from the intestinal crypt.2 8 28 Differenti-
ated organoids (dIEOs) displayed subtle microscopic differ-
ences, along with reduced expression of stem cell markers and 
increased epithelial subset markers (figure 3A). Genome-wide 
DNA methylation analysis of differentiated versus undifferenti-
ated IEOs showed that differentiation did not lead to significant 
DNA methylation changes. The vast majority of CpGs displayed 
either minimal (i.e. <0.1 change in methylation beta value) or no 
change (figure 3B), and differential methylation analysis did not 
yield any significant DMPs.
Next, we investigated the potential impact of gut segment-spe-
cific DNA methylation profiles on regulating mRNA expression 
in dIEOs. We evaluated genes that had shown limited expres-
sion differences between segments in undifferentiated IEOs but 
contained gut segment-specific DMPs and/or DMRs, including 
fatty acid binding protein 6 (FABP6), nuclear receptor subfamily 
1 group H member 4 (NR1H4), mucins (MUC5B and MUC12) 
as well as TFF3 (figure 3C). Strikingly, dIEOs displayed gut 
segment-specific gene expression according to the underlying 
DNA methylation profile (figure 3D). These patterns were 
observed for several genes, which displayed both small bowel 
(ie, TI) and large bowel (ie, SC)-specific mRNA induction 
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Figure 1 DNA methylation profiling of human intestinal epithelial organoids (IEOs) and primary intestinal epithelial cells (IECs). (A) Summary of 
experimental setup. Mucosal biopsies were obtained from distal small bowel (terminal ileum=TI) and distal large bowel (sigmoid colon=SC) and used 
for IEC purification or generation of IEOs. Brightfield images showing established IEOs in culture. (B) Multidimensional scaling plot of genome-wide 
DNA methylation profiles of purified IEC (labelled as ‘x’), mucosa-derived IEOs (labelled as ‘o’), whole biopsies from SC (labelled as ‘b’) and non-
epithelial cell fraction of mucosal biopsies (labelled as ‘n’). (C) Venn diagram indicating the number of significant differentially methylated positions 
(DMPs) as well as overlap between TI and SC purified primary cells and respective organoids (adjusted p<0.01, n=16 IEC, n=10 IEO for each gut 
location.) Organoids were passages 1–11. (D) Scatterplots of average DNA methylation beta values of overlapping gut-segment specific DMPs (see 
figure 1C) in matched IECs and IEOs of the respective gut segment. Pearson correlation r=0.948 (TI) and r=0.955 (SC), p<2.2e-16. (E) Examples of 
differentially methylated regions displaying gut segment-specific methylation levels in both organoids and primary epithelium. Left panel region 
upstream of interleukin-6 receptor (IL6R), right panel special AT-rich sequence-binding protein 2-antisense 1 (SATB2-AS1). Chromosomal location, 
CpGs and DNA methylation (expressed as average beta value (ranging from 0=unmethylated to 1=fully methylated) of sample groups) are displayed. 
(F) Validation of DNA methylation profiles by pyrosequencing of bisulfite-converted DNA, showing per cent of CpG methylation in genomic regions 
of IL6R and SATB2-AS1. Data are presented as mean+SD of n=4 per group and representative for two independent experiments. (G) Heatmap of top 
1000 DMPs, identified by comparing purified TI versus SC epithelium, in the respective organoids profiled at various passages (P). See also online 
supplementary figures S1 and S2. SCo, SC organoids; SCp, SC purified; TIo, TI organoids; TIp, TI purified.  
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profiles. We confirmed that changes in gut segment-specific 
mRNA expression observed on differentiation reflected changes 
in protein expression by immunostaining of FABP6 and MUC5B 
(figure 3E). Our findings suggest that stable DNA methyla-
tion profiles contribute to regulating gut segment-specific gene 
expression and the cellular function of human mucosa-derived 
IEOs on differentiation.
Disruption of gut segment-specific DnA methylation in IeOs 
induces aberrant gene expression
To further confirm our hypothesis, we exposed IEOs to the 
DNA methyltransferase (DNMT) -inhibitor Aza-deoxycytidine 
(AdC). Treatment with DNMT-inhibitor reduced DNA methyl-
ation, primarily at highly methylated loci, and thereby altered 
gut segment-specific signatures (figure 3F). Importantly, 
Figure 2 Transcriptomic profiling of human intestinal epithelial organoids (IEOs) and primary intestinal epithelial cells (IECs). (A) Hierarchical 
clustering and sample heatmap of transcriptomes by RNA-sequencing of IECs and organoids from terminal ileum (TI) and sigmoid colon (SC). (B) 
Heatmap displaying gene expression (ie, rlog-transformed RNA-seq counts) of selected epithelial cell subset markers, genes involved in intestinal 
epithelial innate immune function and regulation of DNA methylation. (C) Venn diagram displaying number as well as overlap of differentially 
expressed genes (DEGs) comparing TI versus SC of primary IEC and organoids. Significance cut-off adj. p<0.01 and log2Fold Change>±1.5, n=11 (IEC) 
and 5 (IEO) for each gut segment. Organoids were passages 1–6. (D) RNA-seq read counts of selected marker genes found to retain gut segment-
specific expression patterns in organoid culture. (E) Validation of differentially expressed marker genes by quantitative PCR on a validation sample 
set, represented as mean+SD, n=3–5 per group, *p<0.05. ALPI, intestinal alkaline phosphatase; CFTR, cystic fibrosis-transmembrane conductance 
regulator; CHGA, chromogranin A; CLDN15, claudin 15; DEFA, defensin alpha; DEFB1, defensin beta 1; DNMT, DNA methyltransferase; LGR5, leucin-
rich repeat containing G protein-coupled receptor 5; LYZ, lysozyme; MUC2, mucin 2; OLFM4, olfactomedin-4; PIGR, polymeric immunoglobulin 
receptor; SATB2, special AT-rich sequence-binding protein 2; SLC5A1, solute carrier family 5 member 1; TET, ten-eleven translocation; TFF3, 
trefoil factor 3; TLR, Toll- like receptor. 
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Figure 3 DNA methylation-dependent, gut segment-specific induction of gene expression in intestinal epithelial organoids (IEOs) during in vitro 
differentiation. (A) (I) Brightfield images of terminal Ileum (TI) and sigmoid colon (SC)-derived IEOs in maintenance medium (TIo and SCo), and 
differentiation medium (dTIo and dSCo), showing change of gross phenotype and (II) change in intestinal stem cell and epithelial cell subset marker 
expression measured by real-time PCR. (B) Histogram of mean difference in DNA methylation (expressed as beta values) of all ~450K tested CpGs 
comparing differentiated with matched undifferentiated intestinal organoids, n=8 derived from four patients (C) DNA methylation level of selected 
CpGs showing stable gut segment-specific differences in undifferentiated and differentiated IEOs, boxplot of n=4 derived from four patients for 
each group. Array cg-identifier is listed on top. (D) Real-time PCR data showing induction of gene expression during in vitro differentiation, n=5 per 
group. (E) Immunofluorescent staining of undifferentiated and differentiated IEOs forFABP6 (red, upper panel) and MUC5B (red, lower panel) protein 
expression. Blue=DAPI, cell nuclei. (F) CpG methylation quantified by pyrosequencing located within ileal and colonic marker genes in IEOs at baseline 
(Ctrl) and after co-culture with DNA methyltransferase inhibitor (Aza-deoxycytidine (AdC)) over 48 hours followed by a 4-day recovery period. Data 
shown as mean+SD of n=4 per group. (G) Gene expression of the markers in (F) shown as absolute values normalised to glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH). Mean+SD, n=3–4 per group. KI67, marker of proliferation Ki-67; LRIG1, leucine-rich repeats and immunoglobulin-like 
domains 1; SI, sucrase isomaltase; SOX9, SRY Box 9; VIL1, villin 1.
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the reduced DNA methylation led to an increase in mRNA 
expression levels of the respective genes, causing expression 
of small bowel-specific genes in SC organoids (ie, FABP6, 
MUC17, CLDN15) and large bowel markers in TI organoids 
(ie, MUC5B and MUC4) (figure 3G). Hence, DNA methylation 
is required to maintain gut segment-specific gene expression 
in IEOs.
Human fetal IeOs display gut segment-specific DnA 
methylation which undergoes dynamic changes in culture
In addition to paediatric mucosal biopsies, we established IEO 
cultures from human fetal proximal gut (FPG, ie, small intestine) 
and fetal distal gut (FDG, ie, large intestine) (figure 4A and online 
supplementary figure S4A). Epithelial origin and purity of cultures 
was confirmed by expression of selected epithelial and non-epi-
thelial marker genes (see online supplementary figure S4B and C). 
Following generation and long-term culture of these fetal organoids, 
we compared their genome-wide DNA methylation profiles with a 
sample set of primary purified human fetal IEC as well as paedi-
atric primary IEC. DNA methylation profiles of primary purified 
fetal IEC separated distinctly from paediatric samples and displayed 
some differences according to gut segment (figure 4B and ref.7). 
Similar to paediatric and adult organoids, early passages of fetal 
organoids clustered close to the respective purified epithelial frac-
tion (figure 4B). Differential DNA methylation analysis indicated 
that fetal organoids retain a large proportion of gut segment-spe-
cific profiles (see online supplementary figure S4D). However, fetal 
IEOs were found to undergo dynamic DNA methylation changes 
in culture as higher passage fetal IEOs appeared to cluster closer 
to paediatric epithelial samples (figure 4B). Given this finding, we 
aimed to assess whether DNA methylation changes occurring in fetal 
organoid cultures could indicate a degree of in vitro maturation. We 
therefore performed differential methylation analysis comparing 
fetal organoids with primary fetal IEC. We tested for an overlap 
of identified DMPs with the methylation changes occurring during 
physiological development from fetal to paediatric epithelium, 
that is, DMPs between fetal and paediatric primary IEC. Strikingly, 
the vast majority of identified significant DMPs both for FPG (ie, 
83%) and FDG (ie, 80%) indeed overlapped (figure 4C and supple-
mentary tables S15 and S16). Moreover, the direction of DNA 
methylation changes was the same and correlated strongly in almost 
all (>99%) overlapping DMPs (figure 4D).
To further assess whether DNA methylation differences 
between higher passage fetal organoids and fetal IEC truly reflect 
in vitro maturation of fetal organoids over time, we plotted a 
heatmap of the DNA methylation levels with increasing passage 
number (figure 4E) for the top 1000 overlapping DMPs that 
displayed the greatest difference between fetal and paediatric 
IEC (from figure 4C). While early passage fetal IEOs displayed 
DNA methylation levels similar to the matching purified fetal 
IEC, methylation profiles of higher passage organoids showed 
high similarities with the respective paediatric IEOs and IECs. 
These maturation patterns occurred in both directions (ie, gain 
and loss of methylation) and were present in both fetal proximal 
and distal organoids (figure 4E). Locus-specific pyrosequencing 
on an additional sample set confirmed DNA methylation of 
genes we had identified to be differentially methylated in fetal 
versus paediatric primary IEC, including the pattern recognition 
receptor Toll-like receptor 4 (TLR4) and the transcription factor 
paired-like homeodomain 1 (PITX1). These genes displayed 
dynamic DNA methylation and gene expression changes in 
fetal organoids during prolonged culture (figure 4F and online 
supplementary figure S4E).
Dynamic transcriptional changes in human fetal organoids 
support in vitro maturation
To assess the transcriptional dynamics in human fetal organoids, 
we performed MDS analysis on RNA-seq profiles, which revealed 
close clustering with paediatric epithelium from the same gut 
segment (figure 5A). Similarly to DNA methylation, differential 
gene expression analysis comparing fetal IEC with fetal organ-
oids demonstrated that the majority of identified DEGs overlap 
with genes differentially expressed between fetal and paediatric 
IEC, with almost all expression changes (i.e. >99%) occurring 
in the same direction (figure 5B, C). In support of our hypothesis 
that fetal organoids undergo in vitro maturation, a heatmap of 
the top 100 overlapping DEGs (see also figure 5B) further illus-
trates distinct transcriptional differences between early and late 
passage fetal organoids with transcriptional profiles appearing 
more similar to paediatric epithelium (figure 5D).
Assuming a functional association between DNA methyl-
ation and gene expression dynamics, we went on to identify 
genes which displayed both dynamic DNA methylation and 
gene expression changes in human fetal organoids. In total, 
we identified 244 and 1090 genes in fetal proximal and distal 
IEOs, respectively (figure 5E as well as see online supplemen-
tary figure S5). Importantly, gene ontology analysis on these 
genes revealed highly significant enrichments for pathways 
involved in ‘system development’ and ‘multicellular organism 
development’ (figure 5F).
TeT1 is involved in regulating in vitro maturation of fetal IeOs
Next, we aimed to identify the mechanisms underlying the 
dynamic changes in DNA methylation suggestive of in vitro 
maturation of fetal IEOs. Ten eleven translocation 1 (TET1) 
encodes an enzyme that plays a key role in active demethyla-
tion of DNA29 and is highly expressed in human fetal intestinal 
epithelium.7 To test whether TET1 contributes to the dynamic 
DNA methylation of fetal IEOs, we applied CRISPR-Cas9 
genome editing to human fetal IEOs and generated a TET1-
knock-out (KO) fetal proximal organoid line (figure 6A and 
online supplementary figure S6). Phenotypically, TET1-defi-
cient fetal organoids appeared viable and did not display any 
obvious differences compared with wildtype (WT) cultures 
during early passages (figure 6B). However, over time, TET1 
KO IEOs showed reduced viability and did not survive beyond 
6 months of in vitro culture (online supplementary figure S6B). 
In addition to these phenotypic differences, a comparison of 
DNA methylation changes over time (ie, 10 weeks) between 
KO and WT organoids demonstrated a reduced loss of meth-
ylation as well as an increased gain of methylation in the KO 
fetal organoids (figure 6C). Similarly, methylation of the top 
1000 maturation-associated CpGs that lose methylation (see 
also Figure 4C and D) revealed a reduced loss but rather a 
gain of DNA methylation between two passaging time points 
of Tet1-KO organoids (figure 6D). Example CpGs that failed 
to undergo demethylation in TET1-KO IEOs are shown in 
figure 6E, F.
In contrast to TET enzymes, DNMTs are involved in main-
tenance as well as active DNA methylation of the mammalian 
genome. We therefore expected them to also be involved in 
regulating in vitro maturation. Accordingly, exposing human 
fetal organoids to DNMT inhibitors led to global demethylation 
(figure 6G). Despite this initial loss of DNA methylation, their 
profile at a later stage revealed a pattern similar to untreated 
organoids at a similar passage, indicating a transient, reversible 
effect (figure 6G and supplementary figure S7).
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Figure 4 DNA methylation dynamics of human fetal intestinal epithelial organoids (IEOs). (A) Schematic illustration of fetal sample processing 
and brightfield microscopy images of fetal IEOs at time points 1, 3 and 5 days after seeding and under long-term maintenance conditions. (B) 
Multidimensional scaling plot of genome-wide DNA methylation profiles of fetal primary intestinal epithelial cells (IECs) and organoids derived 
from fetal proximal gut (FPG) and fetal distal gut (FDG). Data are displayed in the context of paediatric samples (see figure 1). ‘+’ indicates purified 
IEC, ‘number’ represents IEO sample and indicates passage. Arrows indicate longitudinal samples of the same IEO line. Fetal organoids: n=10 
from eight individuals, paediatric organoids: n=10 from seven individuals (ie, three longitudinal samples). (C) Venn diagrams displaying significant 
differentially methylated positions (DMPs) (adj. p<0.01) and their overlaps comparing fetal IECs versus fetal IEOs (n=5–10 per group) and fetal 
IECs versus paediatric IECs (n=5–6 and 16). (D) Correlation plot of fold changes (log2FC) of the overlapping DMPs from (C) (‘maturation-associated 
DMPs’), indicating that nearly all DMPs show the same direction (ie, higher or lower methylation in fetal IEC with almost 100% concordance for 
small intestine, 99.7% concordance for large intestine. Correlation: Pearson’s r=0.946 (proximal) and 0.956 (distal), both adj p<0.0001). (E) Heatmap 
of the top 1000 overlapping DMPs between fetal versus paediatric IECs and fetal IECs versus IEOs (see C) with fetal organoids ordered according 
to passaging times (P1–P23). As a reference, fetal IECs and paediatric sample values are shown as group average (n=5–16). (F) DNA methylation 
assessed by pyrosequencing of CpGs located in the promoter region of Toll-like receptor 4 (TLR4), left, and paired-like homeodomain 1 (PITX1), 
right, during culture of fetal organoids. Sample groups are fetal IEC, early fetal organoids (passage ≤3) and late fetal organoids (passage ≥10) . 
Mean+SD, n=4–5 per group, *p<0.05 and **p<0.01 versus IEC. See also online supplementary figure S4. FDGo, FDG organoids; FDGp, FDG purified 
epithelium; FPGo, FPG organoids; FPGp, FPG purified epithelium; SC sigmoid colon; TI, terminal ileum.  
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Human IeOs derived from ectopic gastric mucosa retain 
altered DnA methylation profiles
As demonstrated above, human IEOs derived from healthy 
intestinal mucosa retain a highly gut segment-specific DNA 
methylation profile in long-term culture despite significant 
environmental changes. We therefore wanted to investigate 
whether IEOs derived from diseased intestinal mucosa also 
retained a specific DNA methylation profile. We clinically 
diagnosed gastric heterotopia in the rectum (GHR) of a paedi-
atric patient (figure 7A). The presence of heterotopic gastric 
mucosa was confirmed using immunostaining for the hindgut 
marker caudal type homeobox 2 (CDX2) and the gastric 
Figure 5 Transcriptional profiling of human fetal intestinal epithelial organoids (IEOs) and correlation with DNA methylation. (A) Multidimensional 
scaling plot of transcriptome data from fetal intestinal epithelial cells (IECs) and fetal organoids in the context of paediatric primary IECs. (B) Overlap 
of differentially expressed genes (DEGs) between fetal IEC versus fetal IEOs, and fetal IEC versus paediatric IEC (n=3–5 per fetal group, n=11 per 
paediatric group), separated for small intestine (left) and large intestine (right). DEG cut-off adj p<0.01 and log2FC>±1.5. (C) Scatterplots of log2FC 
values for each overlapping DEG transcript from the comparisons in (B). Pearson’s correlation r=0.94 (proximal) and r=0.96 (distal), both p<0.001. 
(D) Heatmap of top 1000 DEGs previously identified between fetal and paediatric IEC, shown in fetal organoids. Passage number indicated as ‘P’. 
(E) Venn diagram of overlapping genes that are both differentially methylated and expressed. (F) Five most significant gene ontologies (biological 
process) for genes both differentially methylated and differentially expressed in vivo and in vitro (see figures 4C and 5B), analysed individually for 
proximal and distal gut. See also online supplementary figure S5. DMPS, differentially methylated positions; FDG, fetal distal gut; FPG, fetal proximal 
gut; SC, sigmoid colon; TI, terminal ileum.
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Figure 6 Involvement of ten-eleven translocation 1 (TET1) and DNA methyltransferases (DNMTs) in observed in vitro maturation of human 
fetal intestinal epithelial organoids (IEOs). (A) Gene targeting of TET1 in fetal IEOs: (I) Schematic display of targeting strategy using CRISPR-Cas9 
and targeting vector, (II) confirmation of homology-directed repair (HDR) by PCR. Knockout (KO) line 1 (#1) was used for subsequent analysis. (III) 
Sequencing results of TET1 allele in WT and KO#1 samples aligned to reference. Underline indicates start codon; blue colour indicates gRNA target 
sequence, purple indicates PAM site. (B) Brightfield images of unaltered fetal proximal gut organoids (FPGo), that is, wildtype (WT) and TET1- KO fetal 
small intestinal IEOs derived from the same individual. (C) Quantification of DNA methylation change between two culturing time points in WT and 
TET1- KO. Plotted are the number of CpG positions displaying either loss (left) or gain (right) of DNA methylation in KO compared with WT organoids 
during culture. Time points analysed were WT P12 and P21, KO P8 and P18. p=0.02 (loss) and p=0.03 (gain), paired Wilcoxon test. (D) Heatmap 
displaying DNA methylation of top 1000 maturation-associated differentially methylated positions (see figure 4C) that lose DNA methylation, 
shown in the respective organoid. (E) Example of differentially methylated regions (DMRs) in the genes for the transcription factors homeobox A3 
(HOXA3, left) and GATA binding protein 4 (GATA4, right) between WT and KO at two different time points in culture. KO early=P8, KO late=P18, 
WT early=P12, WT late=P21. (F) Beta values of CpG methylation in CLDN15 at different passages shown in the context of other sample groups. 
Each symbol represents a sample, bar indicates the average. (G) Effect on dynamic DNA methylation changes in response to treatment with DNMT 
inhibitors. Heatmap displaying DNA methylation of top 1000 maturation-associated DMPs that gain methylation between fetal and paediatric small 
intestinal IEC, shown in FPGo at different passages after treatment with Aza-deoxycytidine (AdC). FPG purified epithelium (FPGp) shown as average 
of n=6, terminal ileum purified (TIp) shown as average of n=16, FPGo shown as average of n=2 per condition. See also online supplementary figures 
S6 and S7.
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marker keratin 7 (KRT7). Mixed staining for both gastric (ie, 
KRT7) and intestinal (ie, CDX2) markers in heterotopic tissue 
indicated the presence of a mixed epithelial cell population 
(figure 7B).
Next, we generated IEOs from gastric, rectal and gastric 
heterotopic biopsy samples (figure 7B) and subjected them to 
genome-wide DNA methylation profiling. Unsupervised anal-
ysis revealed distinct methylation differences between organ-
oids derived from heterotopic tissue and adjacent, normal 
rectal mucosa (figure 7C). Interestingly, methylation profiles of 
gastric heterotopic organoids also differed substantially from 
gastric organoids, indicating the presence of disease-specific 
alterations. Importantly, similar to healthy IEOs, DNA meth-
ylation profiles of gastric heterotopia-derived IEOs remained 
overall stable (ie, passages 3–5) independent of gastric or 
colonic culture conditions (see ‘Methods’) (figure 7C). Among 
the genes harbouring stable, differentially methylated CpGs 
were CDX2 and KRT7 (figure 7D) and the gene locus around 
Figure 7 Altered DNA methylation in organoids derived from gastric heterotopia. (A) Endoscopic image of rectal mucosa. Numbers indicate 
gastric heterotopic region (=1), mucosal ulcer (=2) and healthy, unaffected rectal mucosa (=3). (B) (I) Sections of healthy gastric tissue (STO), gastric 
heterotopic tissue in the rectum (GHR) and adjacent healthy rectum (REC). Shown are H&E staining as well as immunohistochemistry staining for 
hindgut marker CDX2 and gastric marker KRT7. (II) Intestinal epithelial organoids (IEOs) derived from stomach, gastric heterotopic and healthy rectal 
tissue. (C) Multidimensional scaling plot of genome-wide DNA methylation of different IEOs from the same donor. Samples were passages 3 and 5, 
indicated by superscript number next to the sample. STO-organoids were grown in gastric medium, REC-organoids in intestinal medium and GHR-
organoids in both gastric (P3 and P5) and intestinal medium (P5). (D) Methylation levels of CpGs located in the genes of CDX2 (left) and KRT7 (right). 
Box plot of n=2–3 IEO per group. (E) Pyrosequencing data showing percentage of methylation in the genes of SATB2-AS1 and GATA2 in heterotopic 
and rectal IEOs. Data shown as mean+SD of n=2 per group. See also online supplementary figure S8. G, gastric heterotopic organoids; R, rectal 
organoids; S, stomach-derived organoids. 
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GATA-binding protein 2 (GATA2) (see online supplementary 
figure S8A,B). Pyrosequencing of additional loci (SATB2-AS1 
and GATA2) confirmed the distinct DNA methylation differ-
ences between heterotopic organoids and healthy rectal muco-
sa-derived organoids which were also found to lead to subtle 
changes in gene expression in the case of GATA2 (figure 7E 
and see online supplementary figure S8C).
DIsCussIOn
IEO cultures are rapidly emerging as powerful models to study 
intestinal epithelial cell biology. Studies on both human and 
murine organoids have demonstrated that organoids can retain 
regional functional properties even in heterotopic  grafts.9 30 
However, the underlying mechanisms remain to be defined.
We have previously shown that DNA methylation profiles 
of the epithelium in the small and large bowel differ substan-
tially.7 12 Our current results using organoid culture indicate that 
these differences originate in the respective intestinal stem cell 
population and do not represent epithelial cell subset differences 
on differentiation. We demonstrate for the first time that IEO 
cultures retain a highly gut segment-specific DNA methylation 
profile that reflects that of primary IEC, despite being removed 
from key environmental factors such as signalling from the 
underlying mucosa. Hence, our study suggests that these epigen-
etic signatures represent a highly stable, epithelial-cell intrinsic 
programme. These findings not only provide further valida-
tion for the reliability of human, mucosa-derived IEOs as an 
important in vitro model system, but also provide novel insight 
into the critical role of stable DNA methylation in keeping the 
memory of epithelial tissue origin over a prolonged in vitro 
culture.
In addition to DNA methylation, we confirmed that transcrip-
tional profiles of paediatric mucosa-derived organoids displayed 
major similarities with primary epithelium derived from the 
respective gut segment.2 However, we also observed signifi-
cant differences in the gene expression profiles of organoids 
compared with primary epithelium. These differences may be 
caused by a number of factors, including the lack of exposure 
to several environmental stimuli such as the underlying mucosa, 
food antigens and adjacent gut microbiota. Additionally, limited 
cellular differentiation into epithelial subsets under maintenance 
culture conditions is likely to contribute to a reduced number 
of regional DEGs in organoids. In line with this, in vitro differ-
entiation led to the expected major changes in gene expres-
sion but no changes to the DNA methylation profile. This is in 
keeping with mouse data that demonstrated minimal differences 
in DNA methylation between crypt and villus epithelium.4 31 
Most importantly, we were able to demonstrate that the level of 
transcriptional changes during cellular differentiation was asso-
ciated with the underlying, gut segment-specific DNA methyla-
tion profile. These findings suggest that stable DNA methylation 
profiles in mucosa-derived human IEOs play a key role in regu-
lating cellular function in a gut segment-specific manner.
The use of immature fetal epithelium represents another 
promising area within the field of IEOs.3 32–34 We further expand 
on these early reports by demonstrating successful generation 
and long-term culture of IEOs derived from human fetal prox-
imal and distal gut. Moreover, in contrast to paediatric and 
adult IEOs, human fetal IEOs undergo substantial, dynamic 
DNA methylation as well as transcriptional changes in culture. 
These striking observations highlight distinct differences in 
the epigenetic plasticity during various stages of physiological 
development. Indeed, a number of studies performed in mice 
have demonstrated substantial changes in DNA methylation of 
IEC both during embryogenesis and during the early postnatal 
phase.4 5 Interestingly, the vast majority of epigenetic and tran-
scriptional changes observed in fetal organoids during long-term 
culture were found to overlap with those that differ between 
purified fetal and paediatric epithelial cells. Together, these find-
ings indicate that human fetal IEOs undergo a degree of in vitro 
maturation and hence could serve as useful models to investi-
gate epithelial development. Furthermore, we show that genome 
editing can be used to elucidate the molecular mechanisms of 
cellular maturation during development.
In addition to modelling human intestinal epithelial biology 
in health, IEOs also hold great promise for studying diseases. 
A number of reports have demonstrated that patient-derived 
organoids display distinct disease-associated phenotypes.35 36 
Here, we demonstrate that human IEOs from diseased, ectopic 
mucosal samples retain an altered DNA methylation signature. 
In light of the observed stability of DNA methylation signatures 
in organoid cultures and its value as a marker for cellular iden-
tity, our data highlight the great potential of organoids to serve 
as translational research tools in studying the role of DNA meth-
ylation in gut diseases.
In summary, our study demonstrates the critical importance 
of precise intestinal epithelial cell-intrinsic epigenetic regulation 
in defining regional gut specification during development, in 
homeostasis and disease pathogenesis.
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